<--- Back to Details
First PageDocument Content
Primary hyperoxaluria / Health / Chemistry / Nephrocalcinosis / GRHPR / Vitamin B6 / Urolithiasis / Calculus / Oxalate / Kidney diseases / Medicine / Hyperoxaluria
Date: 2010-04-29 14:51:54
Primary hyperoxaluria
Health
Chemistry
Nephrocalcinosis
GRHPR
Vitamin B6
Urolithiasis
Calculus
Oxalate
Kidney diseases
Medicine
Hyperoxaluria

I M P R O V I N G PAT I E N T C A R E T H R O U G H E S O T E R I C L A B O R AT O RY T E S T I N G APRIL 2007 Laboratory and Molecular Diagnosis of Primary Hyperoxaluria and Oxalosis

Add to Reading List

Source URL: www.mayomedicallaboratories.com

Download Document from Source Website

File Size: 2,09 MB

Share Document on Facebook

Similar Documents

I M P R O V I N G PAT I E N T C A R E T H R O U G H E S O T E R I C L A B O R AT O RY T E S T I N G  APRIL 2007 Laboratory and Molecular Diagnosis of Primary Hyperoxaluria and Oxalosis

I M P R O V I N G PAT I E N T C A R E T H R O U G H E S O T E R I C L A B O R AT O RY T E S T I N G APRIL 2007 Laboratory and Molecular Diagnosis of Primary Hyperoxaluria and Oxalosis

DocID: 1gGd3 - View Document

SMALL ANIMALS  Renal transplantation in cats with calcium oxalate urolithiasis: 19 cases (1997–2004) Lillian R. Aronson, VMD; Andrew E. Kyles, BVMS, PhD; Alicia Preston;

SMALL ANIMALS Renal transplantation in cats with calcium oxalate urolithiasis: 19 cases (1997–2004) Lillian R. Aronson, VMD; Andrew E. Kyles, BVMS, PhD; Alicia Preston;

DocID: 13SoE - View Document

Metabolic Causes of Tubulointerstitial Disease Steven J. Scheinman A

Metabolic Causes of Tubulointerstitial Disease Steven J. Scheinman A

DocID: 11Uwa - View Document

Renal Involvement in Sarcoidosis Garabed Eknoyan S

Renal Involvement in Sarcoidosis Garabed Eknoyan S

DocID: VT7k - View Document

Allena Pharmaceuticals Presents Phase 1 Data on ALLN-177 at American Society of Nephrology Kidney Week 2014 NEWTON, Mass. – Nov. 17, 2014 – Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company focused

Allena Pharmaceuticals Presents Phase 1 Data on ALLN-177 at American Society of Nephrology Kidney Week 2014 NEWTON, Mass. – Nov. 17, 2014 – Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company focused

DocID: QObE - View Document